IsoPlexis Management
Management criteria checks 3/4
IsoPlexis' CEO is Sean Mackay, appointed in Jan 2014, has a tenure of 9.17 years. total yearly compensation is $1.44M, comprised of 38.1% salary and 61.9% bonuses, including company stock and options. directly owns 2.3% of the company’s shares, worth $696.38K. The average tenure of the management team and the board of directors is 2.2 years and 8.7 years respectively.
Key information
Sean Mackay
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 38.1% |
| CEO tenure | 9.2yrs |
| CEO ownership | 2.3% |
| Management average tenure | 2.2yrs |
| Board average tenure | 8.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | US$1m | US$550k | -US$106m |
| Sep 30 2022 | n/a | n/a | -US$98m |
| Jun 30 2022 | n/a | n/a | -US$104m |
| Mar 31 2022 | n/a | n/a | -US$102m |
| Dec 31 2021 | US$6m | US$420k | -US$92m |
| Sep 30 2021 | n/a | n/a | -US$76m |
| Jun 30 2021 | n/a | n/a | -US$59m |
| Mar 31 2021 | n/a | n/a | -US$41m |
| Dec 31 2020 | US$970k | US$380k | -US$29m |
Compensation vs Market: Sean's total compensation ($USD1.44M) is above average for companies of similar size in the US market ($USD738.70K).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
CEO
Sean Mackay (40 yo)
9.2yrs
Tenure
US$1,443,494
Compensation
Mr. Sean Mackay is Co-Founder of IsoPlexis Corp. and serves as its Chief Executive Officer, President and Director since 2014. Mr. Mackay is an experienced entrepreneur at the convergence of life sciences...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.2yrs | US$1.44m | 2.3% $ 696.4k | |
| Chief Financial Officer | 4.2yrs | US$687.88k | 0.16% $ 49.5k | |
| Senior VP | 1.4yrs | US$719.26k | 0.050% $ 15.2k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| VP of Scientific Alliance Technology & Co-Founder | less than a year | no data | no data | |
| Senior Vice President of Operations | 1.2yrs | no data | no data | |
| VP of Finance & Principal Accounting Officer | 2.2yrs | no data | 0.037% $ 11.1k | |
| Chief Scientific Officer | 3.2yrs | no data | 0.0030% $ 914.6 | |
| Senior Vice President of Sales Operations | no data | no data | no data | |
| Senior Vice President of People Operations | no data | no data | no data | |
| Senior Vice President of Software | 3.2yrs | no data | no data | |
| SVP of Innovation | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
53yo
Average Age
Experienced Management: ISO's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.2yrs | US$1.44m | 2.3% $ 696.4k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Independent Director & Member of Scientific Advisory Board | 8.2yrs | US$148.27k | 0.51% $ 153.8k | |
| Independent Chairman | 9.2yrs | US$182.60k | 0.34% $ 103.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.2yrs | US$156.53k | 0% $ 0 | |
| Independent Director | 9.2yrs | US$45.95k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.2yrs | no data | no data | |
| Independent Director | 1.5yrs | US$148.76k | 0% $ 0 |
8.7yrs
Average Tenure
54yo
Average Age
Experienced Board: ISO's board of directors are considered experienced (8.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/22 14:43 |
| End of Day Share Price | 2023/03/20 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IsoPlexis Corporation is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Tejas Savant | Morgan Stanley |
| Max Masucci | TD Cowen |